Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Expression, purification and antibody preparation using different constructs of PCV2 capsid protein.

Chen F, Yang X, Pang D, Peng Z, Dong M, Liu X, Ouyang H, Ren L.

Int J Biol Macromol. 2014 Jun;67:289-94. doi: 10.1016/j.ijbiomac.2014.03.043. Epub 2014 Mar 30.

PMID:
24690536
2.

Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.

Wu PC, Chen TY, Chi JN, Chien MS, Huang C.

J Biotechnol. 2016 Feb 20;220:78-85. doi: 10.1016/j.jbiotec.2016.01.017. Epub 2016 Jan 18.

PMID:
26795354
3.

Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice.

Sylla S, Cong YL, Sun YX, Yang GL, Ding XM, Yang ZQ, Zhou YL, Yang M, Wang CF, Ding Z.

Microbiol Immunol. 2014 Jul;58(7):398-408. doi: 10.1111/1348-0421.12158.

4.

Identification of one critical amino acid that determines a conformational neutralizing epitope in the capsid protein of porcine circovirus type 2.

Huang LP, Lu YH, Wei YW, Guo LJ, Liu CM.

BMC Microbiol. 2011 Aug 22;11:188. doi: 10.1186/1471-2180-11-188.

5.

Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.

Wu PC, Lin WL, Wu CM, Chi JN, Chien MS, Huang C.

Appl Microbiol Biotechnol. 2012 Sep;95(6):1501-7. doi: 10.1007/s00253-012-4015-2. Epub 2012 Apr 12.

PMID:
22526782
6.

Construction and immunogenicity of recombinant adenovirus expressing the capsid protein of porcine circovirus 2 (PCV2) in mice.

Wang X, Jiang W, Jiang P, Li Y, Feng Z, Xu J.

Vaccine. 2006 Apr 12;24(16):3374-80. Epub 2006 Feb 23.

PMID:
16524646
7.

The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts.

Bucarey SA, Noriega J, Reyes P, Tapia C, Sáenz L, Zuñiga A, Tobar JA.

Vaccine. 2009 Sep 25;27(42):5781-90. doi: 10.1016/j.vaccine.2009.07.061. Epub 2009 Aug 5.

PMID:
19664739
8.

Expression, purification and antibody preparation of PCV2 Rep and ORF3 proteins.

Peng Z, Ma T, Pang D, Su D, Chen F, Chen X, Guo N, Ouyang T, Ouyang H, Ren L.

Int J Biol Macromol. 2016 May;86:277-81. doi: 10.1016/j.ijbiomac.2016.01.073. Epub 2016 Jan 23.

PMID:
26812108
9.

Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice.

Wang YP, Liu D, Guo LJ, Tang QH, Wei YW, Wu HL, Liu JB, Li SB, Huang LP, Liu CM.

Vaccine. 2013 Jan 21;31(5):833-8. doi: 10.1016/j.vaccine.2012.11.062. Epub 2012 Dec 3.

PMID:
23219694
10.

Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies.

Nainys J, Lasickiene R, Petraityte-Burneikiene R, Dabrisius J, Lelesius R, Sereika V, Zvirbliene A, Sasnauskas K, Gedvilaite A.

BMC Biotechnol. 2014 Dec 9;14:100. doi: 10.1186/s12896-014-0100-1.

11.

Generation and immunogenicity of a recombinant pseudorabies virus expressing cap protein of porcine circovirus type 2.

Song Y, Jin M, Zhang S, Xu X, Xiao S, Cao S, Chen H.

Vet Microbiol. 2007 Jan 31;119(2-4):97-104. Epub 2006 Sep 26.

PMID:
17005335
12.

Epitope screening of the PCV2 Cap protein by use of a random peptide-displayed library and polyclonal antibody.

Ge M, Yan A, Luo W, Hu YF, Li RC, Jiang DL, Yu XL.

Virus Res. 2013 Oct;177(1):103-7. doi: 10.1016/j.virusres.2013.06.018. Epub 2013 Jul 8.

PMID:
23845304
13.

[Construction and immunogenicity of recombinant adenoviruses expressing Cap protein of PCV2 and GP5 protein of PRRSV in mice].

Wang X, Li Y, Jiang P.

Sheng Wu Gong Cheng Xue Bao. 2009 Nov;25(11):1639-45. Chinese.

PMID:
20222461
14.

Characterization and potential use of truncated PCV2 capsid protein and its polyclonal antibody for diagnosis of PCV2 infections.

Shuai J, Li X, Chen N, Chen X, Fang W.

Wei Sheng Wu Xue Bao. 2008 Jan;48(1):85-90.

PMID:
18338582
15.

High-level expression and immunogenicity of a porcine circovirus type 2 capsid protein through codon optimization in Pichia pastoris.

Tu Y, Wang Y, Wang G, Wu J, Liu Y, Wang S, Jiang C, Cai X.

Appl Microbiol Biotechnol. 2013 Apr;97(7):2867-75. doi: 10.1007/s00253-012-4540-z. Epub 2012 Nov 10.

PMID:
23143467
16.

Enhanced Th1-biased immune efficacy of porcine circovirus type 2 Cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice.

Wang Y, Lu Y, Liu D, Wei Y, Guo L, Wu H, Huang L, Liu J, Liu C.

Appl Microbiol Biotechnol. 2015 Feb;99(3):1155-63. doi: 10.1007/s00253-014-6167-8. Epub 2014 Dec 9.

PMID:
25487886
17.

Construction and immunogenicity of recombinant swinepox virus expressing capsid protein of PCV2.

Lin HX, Ma Z, Fan HJ, Lu CP.

Vaccine. 2012 Sep 28;30(44):6307-13. doi: 10.1016/j.vaccine.2012.07.082. Epub 2012 Aug 8.

PMID:
22884664
18.

Amino acid mutations in the capsid protein produce novel porcine circovirus type 2 neutralizing epitopes.

Liu J, Huang L, Wei Y, Tang Q, Liu D, Wang Y, Li S, Guo L, Wu H, Liu C.

Vet Microbiol. 2013 Aug 30;165(3-4):260-7. doi: 10.1016/j.vetmic.2013.03.013. Epub 2013 Mar 25.

PMID:
23582511
19.

In vitro expression, monoclonal antibody and bioactivity for capsid protein of porcine circovirus type II without nuclear localization signal.

Zhou JY, Shang SB, Gong H, Chen QX, Wu JX, Shen HG, Chen TF, Guo JQ.

J Biotechnol. 2005 Aug 4;118(2):201-11.

PMID:
15964652
20.

Porcine reproductive and respiratory syndrome virus as a vector: immunogenicity of green fluorescent protein and porcine circovirus type 2 capsid expressed from dedicated subgenomic RNAs.

Pei Y, Hodgins DC, Wu J, Welch SK, Calvert JG, Li G, Du Y, Song C, Yoo D.

Virology. 2009 Jun 20;389(1-2):91-9. doi: 10.1016/j.virol.2009.03.036. Epub 2009 May 6.

Supplemental Content

Support Center